Evidence map›Paper›PMID 40331574›Full record

ArticleJournal of public health (Oxford, England)2025

Sub-national landscape on the years of life lost due to COVID-19 pandemic in the major cities of Southern Philippines.

Zython Paul Lachica

Abstract read
In one paragraph

Article in Journal of public health (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Zython Paul LachicaSt. Cross College, 61 St Giles', Oxford OX1 3LZ, UK.

Funding

Dissertation for the MSc Modelling for Global Health (MGH)Foreign Graduate Scholarship in Priority Fields in Science and TechnologyMindanao Center for DiseaseNuffield Department of MedicinePhilippines' Department of Science and Technology-Science Education Institute (DOST-SEI)
6 · The paper itself

Abstract

backgroundIn Southern Philippines, 5 697 COVID-19 deaths were reported in the major cities from March 2020 to June 2022. The pandemic's impact, despite the relatively modest death toll, was examined by analysing the Years of Life Lost (YLL) derived from disease surveillance datasets.

methodsThe individual YLLs were calculated using the global disease burden approach applying 7% discounting rate and adjusting for sex, age-at-death, and the individual's city-location. The YLLs were then aggregated on a monthly basis. Descriptive analytics were used to characterise the dynamic nature over time of the YLLs.

resultsA total of 51 749.07 YLLs due to COVID-19 were estimated, i.e. 9.09 YLLs per death or 969.49 YLLs per 100 000 population. The monthly YLL ranged from 68.55 to 7 641.12. On average, the age-at-death is 59.68 years with males having younger age-at-death than females. Notably, the weekly COVID-19 incidences and deaths in Southern Philippines showed synchronous peaks.

conclusionThe average age-at-death in Southern Philippines is at least 10 years younger than both international age-at-death estimates and the Philippine life expectancy. The synchronous weekly peaks may highlight distinct pandemic dynamics for a low- and middle-income country. The YLL due to COVID-19 in Southern Philippines, at a sub-national level, is comparable to some country-level estimates, highlighting the impact of the pandemic on this island region alone.

Indexed as

COVID-19Life ExpectancyAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCitiesFemaleHumansInfantInfant, NewbornMaleMiddle AgedPandemicsCOVID-19disease burdenLMICsub-nationalyears of life lost

Identifiers

PMID40331574
PMCPMC12395941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.